Oncomir miR17, Tumour Suppressor miR146a, miR302d, and Oncogene miR19B Expressions in Hepatoblastoma Patients

Ecevit, C. O.Aktas, S.Yildirim, H. T.Demirag, B.Erbay, A.Karaca, I.Celik, A.Demir, B.Ercetin, P.Olgun, N.2023-06-202023-06-2020161545-5009http://hdl.handle.net/11727/9703enginfo:eu-repo/semantics/closedAccessOncomir miR17, Tumour Suppressor miR146a, miR302d, and Oncogene miR19B Expressions in Hepatoblastoma PatientsconferenceObject63S237S237000384818801416